Microsatellite Instability in Gastric Cancer is Associated with Tumor Location and Family History in a High-risk Population from Tuscany
Overview
Authors
Affiliations
We studied the presence of microsatellite instability (MSI) in a series of 108 gastric cancers (GCs) previously identified in an epidemiological study carried out in a high-risk area around Florence. To investigate associations between MSI and GC family history, 34 cases (31.5%) who had a GC-affected first-degree relative were included in the series. A family history positive for colorectal cancer was reported quite rarely (5.6%). The analysis of 6 microsatellite loci in DNA from paired normal tissue and tumor samples microdissected from paraffin-embedded specimens revealed varying degrees of instability: 56 cases (51.8%) did not show instability at any of the 6 loci; 19 (17.6%) showed instability at 1 locus; 16 (14.8%) showed instability at 2 loci; 11 (10.2%) showed instability at 3 loci; 4 (3.7%) showed instability at 4 loci; and 2 (1.9%) showed instability at 5 loci. The replication error-positive (RER+) phenotype, defined as the presence of MSI at 2 or more loci, had a frequency of 30.6% (33 of 108) and tended to be positively associated with female sex, intestinal histological type, advanced tumor stage, vascular invasion, positive GC family history, and blood group of A type. No correlation emerged between age at diagnosis and RER+ phenotype, whereas a significant association with the RER+ phenotype was shown by the antral location. A multivariate analysis adjusting for a selected group of potential confounding factors confirmed the strong association of the RER+ phenotype with the antral location (P = 0.001) and with a positive GC family history (P < 0.05). Survival analyses at 5 and 8 years showed no difference between RER+ and RER- patients, even when corrected for stage distribution. By the microdissection technique, we also used microsatellite allele patterns to investigate intratumoral heterogeneity and genetic relationships between tumors and adjacent dysplasia and/or intestinal metaplasia. Areas of metaplasia and dysplasia demonstrated MSI only in cases with MSI-positive tumors. In MSI-positive tumors, there was consistent evidence of intratumoral microsatellite allele heterogeneity, indicating the presence of genetically divergent tumor cell clones within the same neoplasm.
Boutin M, Gill S Ther Adv Med Oncol. 2023; 15:17588359231162577.
PMID: 37007634 PMC: 10064478. DOI: 10.1177/17588359231162577.
EBV and MSI Status in Gastric Cancer: Does It Matter?.
Nascimento C, Mascarenhas-Lemos L, Silva J, Sousa Marques D, Gouveia C, Faria A Cancers (Basel). 2023; 15(1).
PMID: 36612071 PMC: 9817503. DOI: 10.3390/cancers15010074.
Lee J, Chung S, Choi J, Han Y, Kim J Gastroenterol Res Pract. 2020; 2020:4028136.
PMID: 33144855 PMC: 7599414. DOI: 10.1155/2020/4028136.
Hereditary diffuse gastric cancer: how to look for and how to manage it.
Polom K, Marrelli D, DIgnazio A, Roviello F Updates Surg. 2018; 70(2):161-166.
PMID: 29869323 DOI: 10.1007/s13304-018-0545-1.
Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis.
Ye P, Shi Y, Li A Front Physiol. 2018; 9:368.
PMID: 29719511 PMC: 5914280. DOI: 10.3389/fphys.2018.00368.